Similarly, for DC and B cell markers, DCLK1 expression indeed positively correlated with CD19, CD79A (B cell markers), and activated DC cell markers (HLA+ class II, CD1b, and CD1c), but several studies indicate that B cells play a negative role in tumor immunity through cytokines IL10 and IL35, which showed positive correlation with DCLK1 expression [81,82]. Here, CD1B is linked to neoplasm.